Nasdaq

AC Immune (ACIU) Reports Q1 Loss, Lags Revenue Estimates

AC Immune (ACIU) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.21 per share a year ago. These figures are ...
Nasdaq

AC Immune (ACIU) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

The market expects AC Immune (ACIU) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2023. This widely-known consensus ...
Investing

AC Immune earnings missed, revenue fell short of estimates

Investing.com - AC Immune (NASDAQ: ACIU) reported first quarter EPS of CHF-0.164, worse than the analyst estimate of CHF-0.157. Revenue for the quarter came in at CHF891.46K versus the consensus ...
来自MSN

AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates

AC Immune (ACIU) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to earnings of $0.06 per share a year ago. These figures are ...